03/09/2026
For over two decades, the OPAL multi-purpose reactor has supported the safe and secure production of more than 10 million doses of nuclear medicine used in the diagnosis and treatment of a range of medical conditions and diseases.
At OPAL, crucial radioisotopes are produced, then processed at ANSTO’s manufacturing facilities. Each week, these medicines are delivered to more than 250 hospitals and medical clinics across the country.
In this video, our nuclear medicine supply chain manager explains how it is estimated every Australian is likely to benefit from nuclear medicine and on average will require at least two nuclear medicine procedures in their lifetime.